Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Cardiogenesis Corporation - Cardiogenesis Transmyocardial Laser. The device is indicated Recalled by Cardiogenesis Corporation Due to Following acquisition of Cardiogenesis, we began receiving complaints...

Date: May 1, 2011
Company: Cardiogenesis Corporation
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Cardiogenesis Corporation directly.

Affected Products

Cardiogenesis Corporation - Cardiogenesis Transmyocardial Laser. The device is indicated for use in the treatment of patients with angina (Canadian Cardiovascular Society Class 4) refractory to medical treatment and secondary to objectively demonstrated coronary artery atherosclerosis and with a region of the myocardium with reversible ischemia not amenable to direct coronary revascularization.

Quantity: 2498

Why Was This Recalled?

Following acquisition of Cardiogenesis, we began receiving complaints of sparks, burns, or smoke incidents related to the handpieces.

Where Was This Sold?

US Distribution

About Cardiogenesis Corporation

Cardiogenesis Corporation has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report